AVD · American Vanguard Corp
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q2 FY26 earnings call · Aug 10, 2026TL;DR. American Vanguard reported a 10% decline in Q2 net sales to $117M with adjusted EBITDA falling to $6.6M, but reaffirmed full-year 2026 guidance of $44M–$48M adjusted EBITDA on $530M–$550M sales, while first-half gross margin improved 100 bps to 30% and adjusted EBITDA rose over 20% to $17M.
- + Reaffirmed full-year 2026 guidance of $44M–$48M adjusted EBITDA on $530M–$550M in sales.
- + First-half gross margin improved 100 bps to 30% from 29% on modestly lower revenue.
- + First-half adjusted EBITDA increased more than 20% to $17M from $14M.
- − Q2 gross margin contracted to 30% from 31% on weaker volumes and higher freight costs.
- − International sales declined 18% in Q2 and 13% in H1 on El Niño, raw material pricing, and labor disruptions.
- − Net debt rose to $224.7M at quarter end from $194.7M, driven by working capital build and accounts payable normalization.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $17M | first half 2026 | — |
| Adjusted operating expenses non-GAAP | $33.5M | Q2 FY2026 | — |
| Operating expenses excluding the expenses associated with transformation and product liability c non-GAAP | $33.11M | For the Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Agricultural Inputs — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AVD
this stock
American Vanguard Corp
|
$53.25M | -54.2% | -5.9% | — | 0.7% |
|
CTVA
Corteva, Inc.
|
$52.26B | +15.8% | +2.9% | 51.2 | 3.1% |
|
NTR
Nutrien Ltd.
|
$34.47B | +13.0% | — | — | 1.6% |
|
CF
CF Industries Holdings, Inc.
|
$17.73B | +48.1% | +19.3% | 8.7 | 6.5% |
|
YARIY
Yara International ASA
|
$11.64B | +6.4% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AVD | -9.3% | -25.9% | -24.9% | +0.0% | -54.2% |
| SPY | -0.4% | -0.2% | +12.4% | +0.2% | +12.0% |
| vs SPY | -8.9% | -25.7% | -37.3% | -0.2% | -66.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.